<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - GENTAMICIN</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>GENTAMICIN</h1>

        <p><a href="../drugClass/PHP34544.html">AMINOGLYCOSIDES</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Bacterial eye infections</span>,
            </h4>
            <p class="specificity"><span class="route">To the eye</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1 drop every 2 hours, reduce frequency as infection is controlled and continue for 48 hours after healing, frequency of eye drops depends on the severity of the infection and the potential for irreversible ocular damage; for less severe infection 3&#8211;4 times daily is generally sufficient.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 1 drop every 2 hours, reduce frequency as infection is controlled and continue for 48 hours after healing, frequency of eye drops depends on the severity of the infection and the potential for irreversible ocular damage; for less severe infection 3&#8211;4 times daily is generally sufficient.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Bacterial infection in otitis externa</span>,
            </h4>
            <p class="specificity"><span class="route">To the ear</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 2&#8211;3 drops 3&#8211;4 times a day and apply 2&#8211;3 drops daily, to be used at night.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 2&#8211;3 drops 3&#8211;4 times a day and apply 2&#8211;3 drops daily, to be used at night.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Gram-positive bacterial endocarditis or HACEK endocarditis (in combination with other antibacterials)</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection or by slow intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 mg/kg every 12 hours, intravenous injection to be administered over at least 3 minutes, to be given in a multiple daily dose regimen.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Septicaemia</span>,
                <span class="indication">Meningitis and other CNS infections</span>,
                <span class="indication">Biliary-tract infection</span>,
                <span class="indication">Acute pyelonephritis</span>,
                <span class="indication">Endocarditis</span>,
                <span class="indication">Pneumonia in hospital patients</span>,
                <span class="indication">Adjunct in listerial meningitis</span>,
                <span class="indication">Prostatitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                3&#8211;5 mg/kg daily in 3 divided doses, to be given in a multiple daily dose regimen, divided doses to be given every 8 hours, intravenous injection to be administered over at least 3 minutes.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 5&#8211;7 mg/kg, subsequent doses adjusted according to serum-gentamicin concentration, to be given in a once daily dose regimen.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">CNS infections (administered on expert advice)</span>,
            </h4>
            <p class="specificity"><span class="route">By intrathecal injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 mg daily, increased if necessary to 5 mg daily, seek specialist advice.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical prophylaxis (including joint replacement surgery)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1.5 mg/kg, intravenous injection to be administered over at least 3 minutes., administer dose up to 30 minutes before the procedure, dose may be repeated every 8 hours for high-risk procedures and joint replacement surgery; up to 3 further doses may be given.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                5 mg/kg for 1 dose, administer dose up to 30 minutes before the procedure.</li>
            </ul>
          </section>
        </section>
        
        
        
            <section class="extremesOfBodyWeight">
                <h3>Doses at extremes of body-weight</h3>
              <p>To avoid excessive dosage in obese patients, use ideal weight for height to calculate dose and monitor serum-gentamicin concentration closely.</p>
            </section>
        
        
      </section>






      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>uncommon:</strong> rash, rash, rash, rash in children,
              </p>
              <p>
                <strong>notKnown:</strong> local sensitivity,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intrathecal</ph> use in children</h3>
              <p>For <i>intrathecal</i> or <i>intraventricular</i> injection, use preservative-free intrathecal preparations only.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>For <i>intravenous infusion</i>, dilute in Glucose 5% or Sodium Chloride 0.9%; give over 30 minutes.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph> in children</h3>
              <p>For <i>nebulisation</i>, dilute preservative-free preparation in 3&#8239;mL sodium chloride 0.9%. Administer after physiotherapy and bronchodilators.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (<i>Cidomycin</i>
            <tm tmtype="reg"/>); <i>Gentamicin paediatric injection,</i> Beacon; <i>Gentamicin injection</i> Hospira), give intermittently <i>or</i> via drip tubing in Glucose 5% or Sodium Chloride 0.9%. Suggested volume for intermittent infusion 50&#8211;100&#8239;ml given over 20&#8211;30 minutes (given over 60 minutes for once daily dose regimen).</p>
            </section>
      </section>




      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by ear:</strong>
            avoid prolonged use
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

          <h3>Therapeutic drug monitoring</h3>
        
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For multiple daily dose regimen, one-hour (&#8216;peak&#8217;) serum concentration should be 5&#8211;10&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 2&#8239;mg/litre.</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">In adults</h3>
              <p>For multiple daily dose regimen in endocarditis, one-hour (&#8216;peak&#8217;) serum concentration should be 3&#8211;5&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 1&#8239;mg/litre. Serum-gentamicin concentration should be measured after 3 or 4 doses, then at least every 3 days and after a dose change (more frequently in renal impairment).</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For once-daily dose regimen, consult local guidelines on monitoring serum-gentamicin concentration.</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in neonates</h3>
              <p>Extended interval dose regimen in neonates: pre-dose (&#8216;trough&#8217;) concentration should be less than 2&#8239;mg/litre (less than 1&#8239;mg/litre if more than 3 doses administered); consider monitoring one hour (&#8216;peak&#8217;) concentration in neonates with poor response to treatment, with oedema, with Gram-negative infection, or with birth-weight greater than 4.5&#8239;kg (consider increasing dose if &#8216;peak&#8217; concentration less than 8&#8239;mg/litre in severe sepsis).</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>Once daily dose regimen: pre-dose (&#8216;trough&#8217;) concentration should be less than 1&#8239;mg/litre.</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>Multiple daily dose regimen: one hour (&#8216;peak&#8217;) serum concentration should be 5&#8211;10&#8239;mg/litre ; pre-dose (&#8216;trough&#8217;) concentration should be less than 2&#8239;mg/litre.</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">In children</h3>
              <p>Multiple daily dose regimen for endocarditis: one hour (&#8216;peak&#8217;) serum concentration should be 3&#8211;5&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 1&#8239;mg/litre. Serum-gentamicin concentration should be determined twice each week (more often in renal impairment).</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>Multiple daily dose regimen for cystic fibrosis: one hour (&#8216;peak&#8217;) serum concentration should be 8&#8211;12&#8239;mg/litre; pre-dose (&#8216;trough&#8217;) concentration should be less than 2&#8239;mg/litre.</p>
            </section>
            <section class="therapeuticDrugMonitoring">
              <h3 class="specificity">With <ph outputclass="route">intrathecal</ph> use or <ph outputclass="route">intraventricular</ph> use in children</h3>
              <p>Intrathecal/intraventricular injection: cerebrospinal fluid concentration should not exceed 10&#8239;mg/litre.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">When used by <ph outputclass="route">ear</ph> in children</h3>
              <p>Licensed for use in children (age range not specified by manufacturers).</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">When used by <ph outputclass="route">eye</ph></h3>
              <p>Eye drops may be sourced as a manufactured special or from specialist importing companies.</p>
            </section>
            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intrathecal</ph> use or <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">intraventricular</ph> use in children</h3>
              <p>Local guidelines may vary in the dosing advice provided.</p>
            </section>
            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>Local guidelines may vary in the dosing advice provided for once daily administration.</p>
            </section>
      </section>









      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of GENTAMICIN</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            eye drops,
            oral suspension,
            oral solution,
            cream,

            <div id="PHP75783"><a href="../medicinalForm/PHP75783.html" data-target="#PHP75783" data-action="load">Solution for injection</a></div>
            <div id="PHP0000100"><a href="../medicinalForm/PHP0000100.html" data-target="#PHP0000100" data-action="load">Infusion</a></div>
            <div id="PHP75776"><a href="../medicinalForm/PHP75776.html" data-target="#PHP75776" data-action="load">Ear/eye drops solution</a></div>
            <div id="PHP75799"><a href="../medicinalForm/PHP75799.html" data-target="#PHP75799" data-action="load">Implant</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
